Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal blood monovalent inorganic cation concentration (HP:0010930)help
Parent Node:
expand
Abnormal blood potassium concentration (HP:0011042)help
..Starting node
..expand
Hypokalemia (HP:0002900)help
Term ID: 2900
Name: Hypokalemia
Synonym: Low blood potassium levels
Definition: An abnormally decreased potassium concentration in the blood.
Comments:
Reference: HP:0002900
Genes and Diseases:
 
       Child Nodes:
........expandEpisodic hypokalemia (HP:0012726) help

 Sister Nodes: 
..expandHyperkalemia (HP:0002153) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002900HP:0002900Hypokalemia0AIP CL E G H9049358OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.95
HP:0002900HP:0002900Hypokalemia0AKAP9 CL E G H10142379ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare289
HP:0002900HP:0002900Hypokalemia0ANK2 CL E G H287493ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare539
HP:0002900HP:0002900Hypokalemia0ATP1A1 CL E G H476799OMIM:618314Hypomagnesemia, seizures, and mental retardation 2.4
HP:0002900HP:0002900Hypokalemia0ATP1A1 CL E G H476799ORPHA:564178Primary hypomagnesemia with refractory seizures and intellectual disability4
HP:0002900HP:0002900Hypokalemia0ATP6V0A4 CL E G H50617866OMIM:602722RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR64
HP:0002900HP:0002900Hypokalemia0BMPR1A CL E G H6571076OMIM:174900Juvenile polyposis syndrome.385
HP:0002900HP:0002900Hypokalemia0BSND CL E G H780916512OMIM:602522Bartter syndrome, type 4A, neonatal, with sensorineural deafness.53
HP:0002900HP:0002900Hypokalemia0BSND CL E G H780916512ORPHA:89938Infantile Bartter syndrome with sensorineural deafnessHP:0040281 - Very frequent53
HP:0002900HP:0002900Hypokalemia0CACNA1C CL E G H7751390ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare572
HP:0002900HP:0002900Hypokalemia0CACNA1D CL E G H7761391OMIM:615474Primary aldosteronism, seizures, and neurologic abnormalities.51
HP:0002900HP:0002900Hypokalemia0CACNA1D CL E G H7761391ORPHA:369929Primary hyperaldosteronism-seizures-neurological abnormalities syndromeHP:0040281 - Very frequent51
HP:0002900HP:0002900Hypokalemia0CACNA1S CL E G H7791397ORPHA:681Hypokalemic periodic paralysis247
HP:0002900HP:0002900Hypokalemia0CACNA1S CL E G H7791397OMIM:170400Hypokalemic periodic paralysis, type 1.247
HP:0002900HP:0002900Hypokalemia0CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysis247
HP:0002900HP:0002900Hypokalemia0CACNA1S CL E G H7791397OMIM:188580Thyrotoxic periodic paralysis, susceptibility to, 1.247
HP:0002900HP:0002900Hypokalemia0CALM1 CL E G H8011442ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare18
HP:0002900HP:0002900Hypokalemia0CALM2 CL E G H8051445ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare13
HP:0002900HP:0002900Hypokalemia0CALM3 CL E G H8081449ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare16
HP:0002900HP:0002900Hypokalemia0CASR CL E G H8461514OMIM:601198Hypocalcemia, autosomal dominant 1HP:0040283 - Occasional272
HP:0002900HP:0002900Hypokalemia0CAV3 CL E G H8591529ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare148
HP:0002900HP:0002900Hypokalemia0CDH23 CL E G H6407213733ORPHA:91347TSH-secreting pituitary adenomaHP:0040283 - Occasional636
HP:0002900HP:0002900Hypokalemia0CDKN2A CL E G H10291787ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent289
HP:0002900HP:0002900Hypokalemia0CLCN2 CL E G H11812020ORPHA:404Familial hyperaldosteronism type IIHP:0040283 - Occasional44
HP:0002900HP:0002900Hypokalemia0CLCN2 CL E G H11812020OMIM:605635Hyperaldosteronism, familial, type IIHP:0040284 - Very rare44
HP:0002900HP:0002900Hypokalemia0CLCNKA CL E G H11872026OMIM:613090Bartter syndrome, type 4B, neonatal, with sensorineural deafness.9
HP:0002900HP:0002900Hypokalemia0CLCNKA CL E G H11872026ORPHA:89938Infantile Bartter syndrome with sensorineural deafnessHP:0040281 - Very frequent9
HP:0002900HP:0002900Hypokalemia0CLCNKB CL E G H11882027OMIM:607364Bartter syndrome, type 3.27
HP:0002900HP:0002900Hypokalemia0CLCNKB CL E G H11882027OMIM:613090Bartter syndrome, type 4B, neonatal, with sensorineural deafness.27
HP:0002900HP:0002900Hypokalemia0CLCNKB CL E G H11882027ORPHA:358Gitelman syndromeHP:0040281 - Very frequent27
HP:0002900HP:0002900Hypokalemia0CLCNKB CL E G H11882027ORPHA:89938Infantile Bartter syndrome with sensorineural deafnessHP:0040281 - Very frequent27
HP:0002900HP:0002900Hypokalemia0CLDN10 CL E G H90712033OMIM:617671Helix syndrome.3
HP:0002900HP:0002900Hypokalemia0COL3A1 CL E G H12812201ORPHA:286Vascular Ehlers-Danlos syndromeHP:0040281 - Very frequent749
HP:0002900HP:0002900Hypokalemia0CTNNB1 CL E G H14992514ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent88
HP:0002900HP:0002900Hypokalemia0CTNS CL E G H14972518OMIM:219800Cystinosis, nephropathic178
HP:0002900HP:0002900Hypokalemia0CTNS CL E G H14972518ORPHA:411629Infantile nephropathic cystinosisHP:0040281 - Very frequent178
HP:0002900HP:0002900Hypokalemia0CTNS CL E G H14972518ORPHA:411634Juvenile nephropathic cystinosisHP:0040283 - Occasional178
HP:0002900HP:0002900Hypokalemia0CYP11B1 CL E G H15842591OMIM:202010Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency.112
HP:0002900HP:0002900Hypokalemia0CYP11B1 CL E G H15842591ORPHA:90795Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiencyHP:0040281 - Very frequent112
HP:0002900HP:0002900Hypokalemia0CYP11B1 CL E G H15842591ORPHA:403Familial hyperaldosteronism type IHP:0040283 - Occasional112
HP:0002900HP:0002900Hypokalemia0CYP11B2 CL E G H15852592ORPHA:403Familial hyperaldosteronism type IHP:0040283 - Occasional73
HP:0002900HP:0002900Hypokalemia0CYP17A1 CL E G H15862593ORPHA:90793Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiencyHP:0040282 - Frequent53
HP:0002900HP:0002900Hypokalemia0DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0002900HP:0002900Hypokalemia0EHHADH CL E G H19623247ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent2
HP:0002900HP:0002900Hypokalemia0FXYD2 CL E G H4864026OMIM:154020Hypomagnesemia 2, renal.17
HP:0002900HP:0002900Hypokalemia0GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysis
HP:0002900HP:0002900Hypokalemia0GATM CL E G H26284175OMIM:134600Fanconi renotubular syndrome 1.86
HP:0002900HP:0002900Hypokalemia0GATM CL E G H26284175ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent86
HP:0002900HP:0002900Hypokalemia0GEMIN4 CL E G H5062815717OMIM:617913Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities1
HP:0002900HP:0002900Hypokalemia0HSD11B2 CL E G H32915209OMIM:218030Apparent mineralocorticoid excess.14
HP:0002900HP:0002900Hypokalemia0HSD11B2 CL E G H32915209ORPHA:320Apparent mineralocorticoid excessHP:0040281 - Very frequent14
HP:0002900HP:0002900Hypokalemia0INSR CL E G H36436091ORPHA:508LeprechaunismHP:0040283 - Occasional229
HP:0002900HP:0002900Hypokalemia0INSR CL E G H36436091ORPHA:769Rabson-Mendenhall syndromeHP:0040283 - Occasional229
HP:0002900HP:0002900Hypokalemia0KCNE1 CL E G H37536240ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare148
HP:0002900HP:0002900Hypokalemia0KCNE2 CL E G H99926242ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare43
HP:0002900HP:0002900Hypokalemia0KCNE3 CL E G H100086243ORPHA:681Hypokalemic periodic paralysis73
HP:0002900HP:0002900Hypokalemia0KCNH2 CL E G H37576251ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare901
HP:0002900HP:0002900Hypokalemia0KCNJ1 CL E G H37586255OMIM:241200Bartter syndrome, antenatal, type 2.51
HP:0002900HP:0002900Hypokalemia0KCNJ10 CL E G H37666256ORPHA:199343EAST syndromeHP:0040281 - Very frequent121
HP:0002900HP:0002900Hypokalemia0KCNJ10 CL E G H37666256OMIM:612780Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance.121
HP:0002900HP:0002900Hypokalemia0KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysis10
HP:0002900HP:0002900Hypokalemia0KCNJ18 CL E G H10013444439080OMIM:613239Thyrotoxic periodic paralysis, susceptibility to, 2.10
HP:0002900HP:0002900Hypokalemia0KCNJ2 CL E G H37596263OMIM:170390Andersen cardiodysrhythmic periodic paralysis.193
HP:0002900HP:0002900Hypokalemia0KCNJ5 CL E G H37626266ORPHA:251274Familial hyperaldosteronism type IIIHP:0040281 - Very frequent128
HP:0002900HP:0002900Hypokalemia0KCNJ5 CL E G H37626266OMIM:613677Hyperaldosteronism, familial, type III.128
HP:0002900HP:0002900Hypokalemia0KCNJ5 CL E G H37626266ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare128
HP:0002900HP:0002900Hypokalemia0KCNQ1 CL E G H37846294ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare730
HP:0002900HP:0002900Hypokalemia0MAGED2 CL E G H1091616353OMIM:300971Bartter syndrome, type 5, antenatal, transient.6
HP:0002900HP:0002900Hypokalemia0NDUFAF6 CL E G H13768228625ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent39
HP:0002900HP:0002900Hypokalemia0NOS1AP CL E G H972216859ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare4
HP:0002900HP:0002900Hypokalemia0NR3C1 CL E G H29087978ORPHA:786Generalized glucocorticoid resistance syndromeHP:0040282 - Frequent79
HP:0002900HP:0002900Hypokalemia0OCRL CL E G H49528108ORPHA:534Oculocerebrorenal syndrome of LoweHP:0040282 - Frequent88
HP:0002900HP:0002900Hypokalemia0PKD2 CL E G H53119009OMIM:613095Polycystic kidney disease 2106
HP:0002900HP:0002900Hypokalemia0PRKAR1A CL E G H55739388ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent134
HP:0002900HP:0002900Hypokalemia0SCN10A CL E G H633610582ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare146
HP:0002900HP:0002900Hypokalemia0SCN4A CL E G H632910591ORPHA:682Hyperkalemic periodic paralysisHP:0040283 - Occasional263
HP:0002900HP:0002900Hypokalemia0SCN4A CL E G H632910591ORPHA:681Hypokalemic periodic paralysis263
HP:0002900HP:0002900Hypokalemia0SCN4A CL E G H632910591OMIM:170400Hypokalemic periodic paralysis, type 1.263
HP:0002900HP:0002900Hypokalemia0SCN4A CL E G H632910591OMIM:613345Hypokalemic periodic paralysis, type 2.263
HP:0002900HP:0002900Hypokalemia0SCN4B CL E G H633010592ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare110
HP:0002900HP:0002900Hypokalemia0SCN5A CL E G H633110593ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare1134
HP:0002900HP:0002900Hypokalemia0SCNN1A CL E G H633710599ORPHA:526Liddle syndromeHP:0040281 - Very frequent67
HP:0002900HP:0002900Hypokalemia0SCNN1A CL E G H633710599OMIM:618126Liddle syndrome 3.67
HP:0002900HP:0002900Hypokalemia0SCNN1B CL E G H633810600ORPHA:526Liddle syndromeHP:0040281 - Very frequent61
HP:0002900HP:0002900Hypokalemia0SCNN1B CL E G H633810600OMIM:177200Liddle syndrome 1.61
HP:0002900HP:0002900Hypokalemia0SCNN1G CL E G H634010602ORPHA:526Liddle syndromeHP:0040281 - Very frequent57
HP:0002900HP:0002900Hypokalemia0SCNN1G CL E G H634010602OMIM:618114Liddle syndrome 2.57
HP:0002900HP:0002900Hypokalemia0SERPINA6 CL E G H8661540OMIM:611489Corticosteroid-binding globulin deficiency4
HP:0002900HP:0002900Hypokalemia0SLC12A1 CL E G H655710910OMIM:601678Bartter syndrome, type 1, antenatal.75
HP:0002900HP:0002900Hypokalemia0SLC12A3 CL E G H655910912OMIM:263800Gitelman syndrome.145
HP:0002900HP:0002900Hypokalemia0SLC12A3 CL E G H655910912ORPHA:358Gitelman syndromeHP:0040281 - Very frequent145
HP:0002900HP:0002900Hypokalemia0SLC26A3 CL E G H18113018OMIM:214700Diarrhea 1, secretory chloride, congenital.89
HP:0002900HP:0002900Hypokalemia0SLC2A2 CL E G H651411006OMIM:227810Fanconi-Bickel syndrome.71
HP:0002900HP:0002900Hypokalemia0SLC34A1 CL E G H656911019ORPHA:3337Primary Fanconi renotubular syndromeHP:0040282 - Frequent47
HP:0002900HP:0002900Hypokalemia0SLC4A1 CL E G H652111027OMIM:179800Renal tubular acidosis, distal, autosomal dominant109
HP:0002900HP:0002900Hypokalemia0SLC4A1 CL E G H652111027OMIM:611590Renal tubular acidosis, distal, with hemolytic anemia.109
HP:0002900HP:0002900Hypokalemia0SLC4A4 CL E G H867111030OMIM:604278Renal tubular acidosis, proximal, with ocular abnormalities and mentalretardation89
HP:0002900HP:0002900Hypokalemia0SMAD4 CL E G H40896770OMIM:174900Juvenile polyposis syndrome.504
HP:0002900HP:0002900Hypokalemia0SNTA1 CL E G H664011167ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare118
HP:0002900HP:0002900Hypokalemia0TBX5 CL E G H691011604ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare123
HP:0002900HP:0002900Hypokalemia0TERT CL E G H701511730ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent238
HP:0002900HP:0002900Hypokalemia0TP53 CL E G H715711998ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent911
HP:0002900HP:0002900Hypokalemia0TRDN CL E G H1034512261ORPHA:101016Romano-Ward syndromeHP:0040284 - Very rare145
HP:0002900HP:0002900Hypokalemia0UNC45A CL E G H5589830594OMIM:619377OSTEOOTOHEPATOENTERIC SYNDROME; OOHE
HP:0002900HP:0002900Hypokalemia0USP8 CL E G H910112631OMIM:219090Pituitary adenoma 4, ACTH-secreting, somatic.7
HP:0002900HP:0002900Hypokalemia0ZNRF3 CL E G H8413318126ORPHA:1501Adrenocortical carcinomaHP:0040282 - Frequent
HP:0002900HP:0012726Episodic hypokalemia1ATP1A1 CL E G H476799ORPHA:564178Primary hypomagnesemia with refractory seizures and intellectual disabilityHP:0040282 - Frequent4
HP:0002900HP:0012726Episodic hypokalemia1CACNA1S CL E G H7791397ORPHA:681Hypokalemic periodic paralysisHP:0040280 - Obligate247
HP:0002900HP:0012726Episodic hypokalemia1CACNA1S CL E G H7791397ORPHA:79102Thyrotoxic periodic paralysisHP:0040280 - Obligate247
HP:0002900HP:0012726Episodic hypokalemia1GABRA3 CL E G H25564077ORPHA:79102Thyrotoxic periodic paralysisHP:0040280 - Obligate
HP:0002900HP:0012726Episodic hypokalemia1KCNE3 CL E G H100086243ORPHA:681Hypokalemic periodic paralysisHP:0040280 - Obligate73
HP:0002900HP:0012726Episodic hypokalemia1KCNJ18 CL E G H10013444439080ORPHA:79102Thyrotoxic periodic paralysisHP:0040280 - Obligate10
HP:0002900HP:0012726Episodic hypokalemia1SCN4A CL E G H632910591ORPHA:681Hypokalemic periodic paralysisHP:0040280 - Obligate263


Genes (76) :AIP AKAP9 ANK2 ATP1A1 ATP6V0A4 BMPR1A BSND CACNA1C CACNA1D CACNA1S CALM1 CALM2 CALM3 CASR CAV3 CDH23 CDKN2A CLCN2 CLCNKA CLCNKB CLDN10 COL3A1 CTNNB1 CTNS CYP11B1 CYP11B2 CYP17A1 DEF6 EHHADH FXYD2 GABRA3 GATM GEMIN4 HSD11B2 INSR KCNE1 KCNE2 KCNE3 KCNH2 KCNJ1 KCNJ10 KCNJ18 KCNJ2 KCNJ5 KCNQ1 MAGED2 NDUFAF6 NOS1AP NR3C1 OCRL PKD2 PRKAR1A SCN10A SCN4A SCN4B SCN5A SCNN1A SCNN1B SCNN1G SERPINA6 SLC12A1 SLC12A3 SLC26A3 SLC2A2 SLC34A1 SLC4A1 SLC4A4 SMAD4 SNTA1 TBX5 TERT TP53 TRDN UNC45A USP8 ZNRF3

Diseases (66) :OMIM:219090 ORPHA:101016 OMIM:618314 ORPHA:564178 OMIM:602722 OMIM:174900 OMIM:602522 ORPHA:89938 OMIM:615474 ORPHA:369929 ORPHA:681 OMIM:170400 ORPHA:79102 OMIM:188580 OMIM:601198 ORPHA:91347 ORPHA:1501 ORPHA:404 OMIM:605635 OMIM:613090 OMIM:607364 ORPHA:358 OMIM:617671 ORPHA:286 OMIM:219800 ORPHA:411629 ORPHA:411634 OMIM:202010 ORPHA:90795 ORPHA:403 ORPHA:90793 OMIM:619573 ORPHA:3337 OMIM:154020 OMIM:134600 OMIM:617913 OMIM:218030 ORPHA:320 ORPHA:508 ORPHA:769 OMIM:241200 ORPHA:199343 OMIM:612780 OMIM:613239 OMIM:170390 ORPHA:251274 OMIM:613677 OMIM:300971 ORPHA:786 ORPHA:534 OMIM:613095 ORPHA:682 OMIM:613345 ORPHA:526 OMIM:618126 OMIM:177200 OMIM:618114 OMIM:611489 OMIM:601678 OMIM:263800 OMIM:214700 OMIM:227810 OMIM:179800 OMIM:611590 OMIM:604278 OMIM:619377
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.